BMC pulmonary medicine
June 2, 2026
2 min readIP Score 10/10
Transbronchial lung cryobiopsy in fibrotic hypersensitivity pneumonitis: prognostic differences and intra-lobar variability.
Okuma T; Okuda R; Takemura T; Sawazumi T; Sekine A; Iwasawa T
Abstract
BACKGROUND: Transbronchial lung cryobiopsy (TBLC) is increasingly used to diagnose interstitial lung disease; however, its diagnostic accuracy for fibrotic hypersensitivity pneumonitis (HP) remains uncertain. We aimed to compare disease progression between patients with fibrotic HP diagnosed by TBLC-based multidisciplinary discussion (TBLC-MDD) and those diagnosed by surgical lung biopsy-based MDD (SLB-MDD). METHODS: This single-center retrospective study included patients diagnosed with fibrotic HP via MDD between January 2005 and June 2023. Histopathological findings-chronic fibrosing interstitial pneumonia, airway-centered fibrosis, and poorly formed nonnecrotizing granulomas-were assessed using the 2020 ATS/JRS/ALAT HP guidelines. For SLB-MDD patients who underwent TBLC prior to SLB, changes in diagnostic confidence were evaluated. To compare overall survival (OS) between the TBLC-MDD and SLB-MDD groups, 1:1 propensity score matching was performed. OS was analyzed using the Kaplan-Meier method and Cox proportional hazards models. RESULTS: Histopathological features were significantly less prevalent in TBLC than in SLB specimens. In the first lower-lobe specimen, chronic fibrosing interstitial pneumonia was identified in 26% of TBLC compared to 89% of SLB specimens (p < 0.001). Among 31 SLB-MDD patients with prior TBLC, SLB significantly improved diagnostic confidence in 26 patients (84%; p < 0.001). After propensity score matching (96 pairs), TBLC-MDD patients showed significantly better OS than SLB-MDD patients (HR, 0.436; 95% CI, 0.197-0.963; p = 0.035). Within the TBLC-MDD group, concordance for chronic fibrosing interstitial pneumonia between the first and second lower-lobe specimens was poor (κ = 0.092). The presence of chronic fibrosing interstitial pneumonia in the second lower-lobe specimen independently predicted mortality (HR, 3.233; 95% CI, 1.115-9.376; p = 0.031), whereas findings from the first lower-lobe specimen were not statistically significant. CONCLUSIONS: Patients with fibrotic HP diagnosed by TBLC-MDD exhibited a more favorable prognosis than those diagnosed by SLB-MDD, likely due to insufficient subpleural sampling by TBLC. TBLC should be considered a complementary diagnostic tool to SLB for fibrotic HP, and its interpretative limitations might be carefully addressed during MDD.
This case highlights the diagnostic and management challenges of refractory multisystem sarcoidosis progressing over a two-year period despite advanced biologic therapy.
Clinicians should note that the presence of targetable mutations in non-small cell lung cancer with malignant pleural disease is not associated with improved survival, based on the findings from this study.
Shape-sensing robotic-assisted bronchoscopy achieved a strict diagnostic yield of 70.2% with a low pneumothorax rate of 3.3%, demonstrating that earlier tissue diagnosis of very small pulmonary nodules is feasible and safe for clinical practice.
Up nextJournal of Thoracic DiseaseOct 30, 2026Read
This study introduces ultrasound-guided trans-cannula cryobiopsy of supraclavicular lymph nodes as a novel superficial lymph node approach for tissue acquisition in 10 consecutive patients, though specific numeric success or safety results were not provided in the abstract.
Active infection is not an absolute contraindication to endobronchial valve placement, but positive pressure ventilation significantly increases clinical failure odds with an aOR of 3.00 at P < 0.001.